|
Epidemiological and Clinical Characteristics of Mashhad samples. |
||||||
| Sample |
Risk exposure |
Status |
CD4+ (cells/μl) |
ARV |
PCR gag |
PCR env |
|
|
||||||
| MSH01 |
IDU |
Alive |
428 |
Yes |
Pos |
Neg |
| MSH02 |
IDU |
Alive |
444 |
No |
Pos |
Pos |
| MSH03 |
IDU |
Alive |
111 |
No |
Pos |
Pos |
| MSH04 |
IDU |
Alive |
191 |
No |
Pos |
Pos |
| MSH05 |
Homo |
Dead |
n.a. |
No |
Neg |
Pos |
| MSH06 |
IDU |
Alive |
400 |
No |
Pos |
Pos |
| MSH07 |
IDU |
Alive |
450 |
Yes |
Pos |
Pos |
| MSH08 |
IDU |
Alive |
408 |
No |
Pos |
Pos |
| MSH09 |
IDU |
Alive |
446 |
No |
Pos |
Neg |
| MSH10 |
IDU |
Dead |
n.a. |
No |
Pos |
Pos |
| MSH11 |
IDU |
Alive |
133 |
Yes |
Pos |
Neg |
| MSH12 |
IDU |
Alive |
129 |
No |
Pos |
Pos |
|
n.a, not available; homo, homosexual; IDU, injecting drug user. | ||||||
Naderi et al. Infectious Agents and Cancer 2006 1:4 doi:10.1186/1750-9378-1-4 |
||||||